Direct-acting antivirals reduce risk of premature mortality and liver cancer for people with chronic hepatitis C, study finds
Tuesday, February 12, 2019 - 09:40
in Health & Medicine
The first prospective, longitudinal study investigating treatment of chronic hepatitis C with direct-acting antivirals finds that the treatment is associated with reduced risk of mortality and liver cancer.